Dr. Linda Scarazzini, RPh, MD
Dr. Linda Scarazzini is the Vice President of Pharmacovigilance and Patient Safety at AbbVie. She was formerly Vice President of Medical Safety Evaluation at AbbVie. Dr. Scarazzini has worked in the pharmaceutical industry for 16 years. In 2016, she was selected by her industry peers to serve as the Biopharma Representative on FDA Drug Safety and Risk Management Advisory Committee.
Before joining AbbVie, Dr. Scarazzini served as the Director of the Division of Pharmacovigilance in the Office of Pharmacovigilance and Epidemiology at the FDA’s Center for Drug Evaluation and Research (CDER). She began her career in pharmacovigilance at Sanofi-Aventis, rising to the level of Associate Vice President of Pharmacovigilance and Risk Management.
Board-certified in Internal Medicine, Dr. Scarazzini was Chief Medical Resident at The Graduate Hospital of the University of Pennsylvania. She graduated Summa Cum Laude with a pharmacy degree from Philadelphia College of Pharmacy and Science.
She has co-authored several publications on post-marketing signal evaluation and risk management. In addition to presentations at industry meetings such as Drug Information Association, she frequently presents on leadership. She is a 1994 graduate of Temple University School of Medicine.